Osteoclasts influence MM progression directly by releasing cytokines, such as IL-6, IL-3, and others, or expressing receptor activator of NF-kB ligand (RANKL), which leads to resorption of the bone matrix [62,63,64,65]. This evidence concerns the gene IL6 and Miyoshi myopathy.